Intrinsic Value of S&P & Nasdaq Contact Us

Liquidia Corporation LQDA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$50.67
+30.9%

Liquidia Corporation (LQDA) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 6 recommend buying, 0 recommend holding, and 1 recommend selling.

The analyst consensus price target for LQDA is $50.67, representing a +30.9% upside from the current price of $38.71. Price targets range from a low of $47.00 to a high of $55.00.

Analyst Consensus — LQDA

Buy
Strong Buy
1
Buy
5
Hold
0
Sell
1
Strong Sell
0
7 analysts
Price Targets
Consensus$50.67
High$55.00
Low$47.00
Median$50.00
Last Month Avg-
Last Quarter Avg$55.00
Last Year Avg$41.00
All-Time Count15
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message